IFP Advisors, Inc - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 184 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q3 2020$11,0002590.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2018$12,000
-25.0%
1360.0%0.00%
-100.0%
Q2 2018$16,000
+100.0%
1360.0%0.00%
Q1 2018$8,0000.0%1360.0%0.00%
Q4 2017$8,000
+33.3%
1360.0%0.00%
Q3 2017$6,000
+20.0%
1360.0%0.00%
Q2 2017$5,000
+25.0%
1360.0%0.00%
Q1 2017$4,000
-60.0%
136
-56.3%
0.00%
Q4 2016$10,000
+100.0%
311
+77.7%
0.00%
Q3 2016$5,000
-86.1%
175
-89.4%
0.00%
-100.0%
Q2 2016$36,000
-36.8%
1,651
-3.7%
0.00%
-50.0%
Q4 2015$57,0001,7140.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,546,097$66,590,0009.91%
RA Capital Management 1,539,586$66,310,0006.70%
SENZAR ASSET MANAGEMENT, LLC 255,128$10,988,0004.20%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 158,315$6,819,0001.56%
Sarissa Capital Management LP 105,000$4,522,0001.54%
Ghost Tree Capital, LLC 50,000$2,154,0001.52%
BENNETT LAWRENCE MANAGEMENT L L C/NY 118,445$5,102,0000.90%
WALL STREET ASSOCIATES 219,200$9,441,0000.81%
Granite Point Capital Management, L.P. 25,000$1,077,0000.74%
BAILARD, INC. 91,500$3,941,0000.61%
View complete list of ENANTA PHARMACEUTICALS INC shareholders